Disease control rate (DCR) was significantly lower in ILD and IPF patients than in non-ILD patients regardless of the presence of EGFR mutation (67 or 53 vs. 85 %, respectively). The gene discussed is EGFR; the disease is idiopathic pulmonary fibrosis.